A Resource for Healthcare and Social Services Professionals
A study led by NIDA researchers, published in World Psychiatry, investigates the rates of COVID-19 breakthrough infections among vaccinated individuals with substance use disorders (SUDs) compared to those without SUDs. The study addresses the effects of comorbidities and social determinants of health as they correlate with risks for substance use, affecting breakthrough infection risks.
To read Science Daily‘s summary of the article click here.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.